ALPHAVAX
AlphaVax develops a range of vaccine products for infectious diseases, biodefense, and cancer. It uses alphavaccine vector platform technology to generate a portfolio of vaccine candidates for infectious disease prevention and cancer immunotherapy. AlphaVax was founded by Jonathan F. Smith and is based in Durham, North Carolina.
ALPHAVAX
Industry:
Biotechnology Health Care Medical
Founded:
1997-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.alphavax.com
Total Employee:
51+
Status:
Active
Contact:
919-595-0400
Email Addresses:
[email protected]
Total Funding:
48.42 M USD
Technology used in webpage:
SPF SSL By Default Google Font API Microsoft Exchange Online Amazon Office 365 Mail Google Maps AJAX Libraries API GoDaddy DNS Google Maps API
Similar Organizations
Henry Ford Health System
Henry Ford Health System (HFHS) is one of the nation’s leading comprehensive, integrated health systems.
Current Employees Featured
Founder
Official Site Inspections
http://www.alphavax.com
- Host name: cloudproxy10006.sucuri.net
- IP address: 192.124.249.6
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "AlphaVax"
AlphaVax - Crunchbase Company Profile & Funding
AlphaVax develops a range of vaccine products for infectious diseases, biodefense, and cancer. It uses alphavaccine vector platform technology to … See details»
Alphavax, Inc. Company Profile | Research Triangle Park, NC ...
Find company research, competitor information, contact details & financial data for Alphavax, Inc. of Research Triangle Park, NC. Get the latest business insights from Dun & Bradstreet. See details»
AlphaVax 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for AlphaVax. Use the PitchBook Platform to explore the full profile. See details»
AlphaVax - Products, Competitors, Financials, Employees, …
About AlphaVax AlphaVax is a clinical-stage biopharmaceutical company that focuses on the development of vaccines for infectious diseases and cancers using RNA particle technology. … See details»
AlphaVax Company Profile - Office Locations, Competitors ... - Craft
See insights on AlphaVax including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. See details»
AlphaVax, Inc - VentureRadar
AlphaVax develops vaccine technology with applications in infectious disease, cancer, and biodefense threats. ... Find out more about AlphaVax, Inc, Misc, Biologics, Vaccines and … See details»
About - Our Journey - AlphaVax Inc. Company
AlphaVax's partners have included Novartis Vaccines and Diagnostics, Inc., for Cytomegaolvirus (CMV), and certain US government agencies for specific vaccine treatments against certain … See details»
AlphaVax, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore AlphaVax, Inc. with its drug pipeline, therapeutic area, technology platform, 7 clinical trials, 8 news, and 2 literature, Disease Domain:Infectious Diseases ... See details»
AlphaVax Inc - Company Profile and News - Bloomberg Markets
Company profile page for AlphaVax Inc including stock price, company news, executives, board members, and contact information See details»
AlphaVax, Durham NC - Company Profile | BizStanding
The organization Alphavax was registered in 1998. We have information about 17 employees who work here. Alphavax is situated in NC. Another office of the organization is located at 2 … See details»
Directors AlphaVax Inc. Company - Board
Meet the dedicated board members shaping the future of AlphaVax Inc. Learn about their expertise and contributions. See details»
AlphaVax, Inc. | Insights
Novartishas acquired an investigational cytomegalovirus (CMV) vaccine programme from the US-based vaccine developer AlphaVax for $20 million. The acquisition of the CMV programme … See details»
Alphavax Human Vaccines, Inc. Company Profile | Durham, NC ...
Find company research, competitor information, contact details & financial data for Alphavax Human Vaccines, Inc. of Durham, NC. Get the latest business insights from Dun & Bradstreet. See details»
AlphaVax Inc. Company - Investors
Connect with AlphaVax Inc. company’s investors. Stay abreast of financial updates and the latest developments in our vaccine development. See details»
AlphaVax - Funding, Financials, Valuation & Investors
AlphaVax develops a range of vaccine products for infectious diseases, biodefense, and cancer. See details»
Contact - AlphaVax Inc. Company
Contact AlphaVax Inc. company for questions, collaborations, or additional information. Reach out today. See details»
AlphaVax - Contacts, Employees, Board Members, Advisors & Alumni
AlphaVax develops a range of vaccine products for infectious diseases, biodefense, and cancer. See details»
Healthcare Technology - AlphaVax Inc.
Explore the AlphaVaccine Platform, a cornerstone of our vaccine development, driven by proprietary RNA healthcare technology. Learn more. See details»
RNA Technology - AlphaVax Inc.
The alphavaccine technology is based on AlphaVax’s proprietary (RNA particle) replicon vector platform derived from attenuated strains of the alphavirus, Venezuelan equine encephalitis … See details»
What charging for COVID-19 vaccines means for Albertans going …
21 hours ago Alberta's new path makes it an outlier in Canada, prompting questions about why the province has diverged from national recommendations on vaccines, what the timeline is for … See details»